Search research articles
Contact Us
Filters
Showing results (181-190 of 208) with videos related to
Page
of 21
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Prognostic impact of age and MDS-associated mutations in <i>NPM1</i> -mutated AML
Vivian M Liu, Megan Othus, Jasmine Naru, et al.
American Journal of Hematology
|
May 21, 2024
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis
Camille Kockerols, Peter J M Valk, Stéphanie Dulucq, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Chronic myelogenous leukemia, version 1.2015
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
BMC Cancer
|
April 4, 2018
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia
Ehab Atallah, Charles A Schiffer, Kevin P Weinfurt, et al.
Biomarker Research
|
August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Era L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 26, 2006
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen
H Joachim Deeg, Barry E Storer, Michael Boeckh, et al.
Leukemia & Lymphoma
|
March 20, 2023
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia
Ryan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, et al.
Blood
|
April 7, 2006
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction
Carla S Wilson, George S Davidson, Shawn B Martin, et al.
Blood
|
May 5, 2016
CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML
Julia E Maxson, Rhonda E Ries, Yi-Cheng Wang, et al.
JAMA Oncology
|
November 12, 2020
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
Ehab Atallah, Charles A Schiffer, Jerald P Radich, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 208) with videos related to
Sort By:
Page
of 21
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Prognostic impact of age and MDS-associated mutations in <i>NPM1</i> -mutated AML
Vivian M Liu, Megan Othus, Jasmine Naru, et al.
American Journal of Hematology
|
May 21, 2024
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis
Camille Kockerols, Peter J M Valk, Stéphanie Dulucq, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Chronic myelogenous leukemia, version 1.2015
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
BMC Cancer
|
April 4, 2018
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia
Ehab Atallah, Charles A Schiffer, Kevin P Weinfurt, et al.
Biomarker Research
|
August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Era L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 26, 2006
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen
H Joachim Deeg, Barry E Storer, Michael Boeckh, et al.
Leukemia & Lymphoma
|
March 20, 2023
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia
Ryan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, et al.
Blood
|
April 7, 2006
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction
Carla S Wilson, George S Davidson, Shawn B Martin, et al.
Blood
|
May 5, 2016
CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML
Julia E Maxson, Rhonda E Ries, Yi-Cheng Wang, et al.
JAMA Oncology
|
November 12, 2020
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
Ehab Atallah, Charles A Schiffer, Jerald P Radich, et al.
Page
of 21